Sotalol Hydrochloride Tablet
Product Images NDC 71610-474

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71610-474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

71610 0474 60

71610 0474 60
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Age About 2 Years Or Younger (Age Factor)

Age About 2 Years Or Younger (Age Factor)
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
This text provides information about the P-values related to Recurrence-Free Survival for the drug Oral Sotalol compared to Placebo. It includes different dosages of Oral Sotalol (80 mg, 120 mg, and 160 mg) and their respective P-values. It is mostly likely related to a clinical study evaluating the effectiveness of Oral Sotalol in preventing recurrence of a certain medical condition.*
FDA Label Image

Figure 3 (Figure3)

Figure 3 (Figure3)
FDA Label Image

Molecular Structure (Molecularstructure)

Molecular Structure (Molecularstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.